🇺🇸 Ritonavir (Norvir) in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 14

Most-reported reactions

1. Foetal Exposure During Pregnancy — 3 reports (21.43%)
2. Maternal Drugs Affecting Foetus — 2 reports (14.29%)
3. Ventricular Septal Defect — 2 reports (14.29%)
4. Accessory Auricle — 1 report (7.14%)
5. Alanine Aminotransferase Increased — 1 report (7.14%)
6. Anaemia — 1 report (7.14%)
7. Aspartate Aminotransferase Increased — 1 report (7.14%)
8. Congenital Foot Malformation — 1 report (7.14%)
9. Cryptorchism — 1 report (7.14%)
10. Drug-Induced Liver Injury — 1 report (7.14%)

Source database →

Frequently asked questions

Is Ritonavir (Norvir) approved in United States?

Ritonavir (Norvir) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ritonavir (Norvir) in United States?

Germans Trias i Pujol Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.